alexa Novel Bioconjugate Carriers As Drugs Ver. 3.0: Design Language, Merits And Bench To Bedside Transformation
ISSN: 2329-6631

Journal of Developing Drugs
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

International Conference and Exhibition on Pharmaceutical Development and Technology
April 24-26, 2017 Dubai, UAE

Mohamed Ismail Nounou
Appalachian College of Pharmacy, USA
Posters & Accepted Abstracts: J Develop Drugs Res
DOI: 10.4172/2329-6631-C1-024
Abstract
Observing the research and development for novel and innovative drug carrier systems in the past fifteen years has been thrilling and exciting. The research trend moving from prodrug technologies based on minimal chemical modifications to comply Lipiniski rule of five (Drugs Ver 1.0), to novel nano-carriers such as nanoparticles, nanoemulsaions, vesicular systems and polymeric and peptidomemetic systems (Drugs Ver 2.0) to finally novel bioresponsive smart bioconjugates (Drugs Ver 3.0). This review would focus on novel smart bioconjugates, current innovations in its design language, advantages, industrialization, scaling-up, current patent status and its transformation from bench (Lab. small scale production) to bedside (industrial manufacturing stage). Finally, this review will focus on the role of pharmaceutical formulators in transitioning novel bioconjugates from synthetic chemical compounds to final dosage forms, overcoming the hurdles of synthesis reproducibility and purity of the final bioconjugates and the associated adjuvants used in the chemical synthesis. Innovative and updated strategies in formulation design and development are required to take bioconjugate systems efficiently from bench to bedside.
Biography

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords